Summit Therapeutics Inc.
SMMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15,358,973 | $15,802,847 | $14,237,486 | $13,164,375 |
| - Cash | $238,875 | $297,872 | $211,526 | $104,862 |
| + Debt | $5,428 | $5,553 | $6,450 | $7,218 |
| Enterprise Value | $15,125,526 | $15,510,528 | $14,032,410 | $13,066,731 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$42 | -$37 | -$25 | -$14,940 |
| % Margin | – | – | – | – |
| EBITDA | -$231,751 | -$565,671 | -$62,888 | -$61,145 |
| % Margin | – | – | – | – |
| Net Income | -$231,793 | -$565,708 | -$62,913 | -$61,203 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.76 | -0.085 | -0.083 |
| % Growth | 59.2% | -792% | -2.7% | – |
| Operating Cash Flow | -$95,019 | -$66,744 | -$61,168 | -$48,673 |
| Capital Expenditures | -$71 | -$13 | -$422 | -$14 |
| Free Cash Flow | -$95,091 | -$66,744 | -$61,590 | -$48,687 |